Delisting riskPopularity #4,858
Citius Oncology (CTOR)
Commercializing LYMPHIR for relapsed or refractory cutaneous T-cell lymphoma.
$1.04
vs last close−0.04 (−3.27%)
Something off on this page? Send us feedback.
Next report
Dec 17, 26
estimated · in 85 days
EPS estimate
−$0.19
Revenue estimate
$5.8M
Fiscal quarter
Q4 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Dec '25Feb '26May '26Aug '26Dec '26
Reported−$0.09−$0.11−$0.08−$0.06−$0.06−$0.27−$0.08Pending
Estimate−$0.06−$0.09−$0.15−$0.06−$0.04−$0.01−$0.07−$0.19
Surprise−50.0%−22.2%+46.7%0.0%−50.0%−2,600.0%−14.3%—
RevenueReportedEstimate
Feb '25May '25Aug '25Dec '25Feb '26May '26Aug '26Dec '26
Reported————$3.9M$1.7M$1.5MPending
Estimate—$5.7M——$4.4M$7.0M$2.5M$5.8M
Surprise————−9.8%−76.2%−40.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2028 | $0.00 | — | — |
| Jun 2028 | $0.00 | — | — |
| Mar 2028 | $0.00 | — | — |
| Dec 2027 | $0.00 | — | — |
| Sep 2027 | $0.10 | — | — |
| Jun 2027 | −$0.04 | — | — |
| Mar 2027 | $0.04 | — | — |
| Dec 2026 | $0.10 | — | — |
| Dec 2026 | −$0.19 | — | — |
| Aug 2026 | −$0.07 | −$0.08 | −14.3% |
| May 2026 | −$0.01 | −$0.27 | −2,600.0% |
| Feb 2026 | −$0.04 | −$0.06 | −50.0% |
| Dec 2025 | −$0.06 | −$0.06 | 0.0% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Dec 2024 | |||
| Mar 2024 | |||
| Dec 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Apr 2021 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Sep 2028 | $0.00 | — | — | $42.5M | — | — | — |
| Jun 2028 | $0.00 | — | — | $40.9M | — | — | — |
| Mar 2028 | $0.00 | — | — | $37.8M | — | — | — |
| Dec 2027 | $0.00 | — | — | $36.2M | — | — | — |
| Sep 2027 | $0.10 | — | — | $31.4M | — | — | — |
| Jun 2027 | −$0.04 | — | — | $28.5M | — | — | — |
| Mar 2027 | $0.04 | — | — | $20.9M | — | — | — |
| Dec 2026 | $0.10 | — | — | $14.3M | — | — | — |
| Dec 17, 2026 | −$0.19 | — | — | $5.8M | — | — | — |
| Aug 14, 2026 | −$0.07 | −$0.08 | −14.3% | $2.5M | $1.5M | −40.2% | −18.7% |
| May 15, 2026 | −$0.01 | −$0.27 | −2,600.0% | $7.0M | $1.7M | −76.2% | −2.1% |
| Feb 13, 2026 | −$0.04 | −$0.06 | −50.0% | $4.4M | $3.9M | −9.8% | +3.4% |
| Dec 23, 2025 | −$0.06 | −$0.06 | 0.0% | — | — | — | +1.6% |
| Aug 12, 2025 | |||||||
| May 14, 2025 | |||||||
| Feb 14, 2025 | |||||||
| Dec 27, 2024 | |||||||
| Mar 31, 2024 | |||||||
| Dec 31, 2023 | |||||||
| Sep 30, 2023 | |||||||
| Jun 30, 2023 | |||||||
| Mar 31, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Sep 30, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Apr 30, 2021 |